Search Ontology:
ChEBI
1-eicosanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine
- Term ID
- CHEBI:86221
- Synonyms
-
- (2R)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(icosanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
- 1-Arachidonyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine
- GPCho(20:0/22:6n3)
- GPCho(20:0/22:6w3)
- PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
- PC(20:0/22:6n3)
- PC(20:0/22:6w3)
- Phosphatidylcholine(20:0/22:6n3)
- Phosphatidylcholine(20:0/22:6w3)
- Definition
- A phosphatidylcholine 42:6 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.
- References
-
- HMDB:HMDB0008288
- LIPID_MAPS_instance:LMGP01011028
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
Show first 5 Terms
Phenotype
Phenotype resulting from 1-eicosanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine
Phenotype where environments contain 1-eicosanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine
Phenotype modified by environments containing 1-eicosanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine
Human Disease Model